University of Dundee An intellectual disability syndrome with single nucleotide variants in O-GlcNAc Transferase Pravata,

Intellectual disability (ID) is a neurodevelopmental condition that affects ~1% of the world population. In total 5−10% of ID cases are due to variants in genes located on the X chromosome. Recently, variants in OGT have been shown to co-segregate with X-linked intellectual disability (XLID) in multiple families. OGT encodes O-GlcNAc transferase (OGT), an essential enzyme that catalyses O-linked glycosylation with β-N-acetylglucosamine (O-GlcNAc) on serine/threonine residues of thousands of nuclear and cytosolic proteins. In this review, we compile the work from the last few years that clearly delineates a new syndromic form of ID, which we propose to classify as a novel Congenital Disorder of Glycosylation (OGT-CDG). We discuss potential hypotheses for the underpinning molecular mechanism(s) that provide impetus for future research studies geared towards informed interventions.

[1]  S. Pajusalu,et al.  A missense mutation in the catalytic domain of O‐GlcNAc transferase links perturbations in protein O‐GlcNAcylation to X‐linked intellectual disability , 2019, FEBS letters.

[2]  D. V. van Aalten,et al.  Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability , 2019, Proceedings of the National Academy of Sciences.

[3]  J. Hanover,et al.  Nutrient-Driven O-GlcNAcylation at Promoters Impacts Genome-Wide RNA Pol II Distribution , 2018, Front. Endocrinol..

[4]  Tyrone D. Cannon,et al.  Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence , 2018, Nature Genetics.

[5]  R. Stevenson,et al.  X‐linked intellectual disability update 2017 , 2018, American journal of medical genetics. Part A.

[6]  M. Shaw,et al.  O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling , 2018, The Journal of Biological Chemistry.

[7]  E. Morava,et al.  CDG Therapies: From Bench to Bedside , 2018, International journal of molecular sciences.

[8]  G. Matthijs,et al.  Congenital disorders of glycosylation (CDG): Quo vadis? , 2017, European journal of medical genetics.

[9]  M. Fobker,et al.  SLC39A8 deficiency: biochemical correction and major clinical improvement by manganese therapy , 2017, Genetics in Medicine.

[10]  D. V. van Aalten,et al.  A mutant O-GlcNAcase enriches Drosophila developmental regulators. , 2017, Nature chemical biology.

[11]  R. Pfundt,et al.  Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability , 2017, The Journal of Biological Chemistry.

[12]  Darren J. Fitzpatrick,et al.  Fam60a defines a variant Sin3a‐Hdac complex in embryonic stem cells required for self‐renewal , 2017, The EMBO journal.

[13]  A. Pandey,et al.  Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability. , 2017, Omics : a journal of integrative biology.

[14]  G. Matthijs,et al.  Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects , 2017, The Journal of clinical endocrinology and metabolism.

[15]  Tao Wang,et al.  Identification and characterization of a missense mutation in the O-linked β-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability , 2017, The Journal of Biological Chemistry.

[16]  J. Hanover,et al.  Nutrient-driven O-linked N-acetylglucosamine (O-GlcNAc) cycling impacts neurodevelopmental timing and metabolism , 2017, The Journal of Biological Chemistry.

[17]  T. Meitinger,et al.  CAD mutations and uridine-responsive epileptic encephalopathy , 2017, Brain : a journal of neurology.

[18]  R. Schalock,et al.  The Relation Between Intellectual Functioning and Adaptive Behavior in the Diagnosis of Intellectual Disability. , 2016, Intellectual and developmental disabilities.

[19]  L. Vissers,et al.  Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.

[20]  A. Munnich,et al.  Nonsyndromic X-linked intellectual deficiency in three brothers with a novel MED12 missense mutation [c.5922G>T (p.Glu1974His)] , 2015, Clinical case reports.

[21]  D. Vocadlo,et al.  O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains. , 2015, Nature chemical biology.

[22]  C. Skinner,et al.  Affected Kindred Analysis of Human X Chromosome Exomes to Identify Novel X-Linked Intellectual Disability Genes , 2015, PloS one.

[23]  K. Friend,et al.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes , 2015, Molecular Psychiatry.

[24]  C. Slawson,et al.  O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis , 2014, Front. Endocrinol..

[25]  D. Vocadlo,et al.  The Emerging Link between O-GlcNAc and Alzheimer Disease* , 2014, The Journal of Biological Chemistry.

[26]  L. Wells,et al.  Functional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology , 2014, Critical reviews in biochemistry and molecular biology.

[27]  W. Herr,et al.  HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase , 2013, Science.

[28]  Yu-Chieh Wang,et al.  Protein post-translational modifications and regulation of pluripotency in human stem cells , 2013, Cell Research.

[29]  J. Gécz,et al.  A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disability. , 2012, American journal of human genetics.

[30]  G. Hart,et al.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.

[31]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[32]  Shekhar Saxena,et al.  Prevalence of intellectual disability: a meta-analysis of population-based studies. , 2011, Research in developmental disabilities.

[33]  W. Herr,et al.  O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1 , 2011, Cell.

[34]  Piotr Sliz,et al.  Structure of human O-GlcNAc transferase and its complex with a peptide substrate , 2010, Nature.

[35]  G. Hart,et al.  O-GlcNAc signaling: a metabolic link between diabetes and cancer? , 2010, Trends in biochemical sciences.

[36]  G. Hart,et al.  O-GlcNAc Transferase Regulates Mitotic Chromatin Dynamics* , 2010, The Journal of Biological Chemistry.

[37]  D. V. van Aalten,et al.  Substrate and product analogues as human O-GlcNAc transferase inhibitors , 2010, Amino Acids.

[38]  M. Wolfert,et al.  Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc. , 2010, Nature chemical biology.

[39]  Matthew S Macauley,et al.  Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase. , 2010, Biochimica et biophysica acta.

[40]  Matthew S Macauley,et al.  Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc) , 2009, Proceedings of the National Academy of Sciences.

[41]  Jürg Müller,et al.  Essential Role of the Glycosyltransferase Sxc/Ogt in Polycomb Repression , 2009, Science.

[42]  L. Wells,et al.  O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development , 2009, BMC Developmental Biology.

[43]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[44]  D. V. van Aalten,et al.  GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation , 2009, The Biochemical journal.

[45]  G. Hart,et al.  O-GlcNAc modification in diabetes and Alzheimer's disease. , 2007, Molecular bioSystems.

[46]  S. Burden,et al.  GA-Binding Protein Is Dispensable for Neuromuscular Synapse Formation and Synapse-Specific Gene Expression , 2007, Molecular and Cellular Biology.

[47]  Jamel Chelly,et al.  Genetics and pathophysiology of mental retardation , 2006, European Journal of Human Genetics.

[48]  Jonathan C Trinidad,et al.  O-Linked N-Acetylglucosamine Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity Chromatography and Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[49]  J. Hanover,et al.  The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.

[50]  F. L. Raymond,et al.  X linked mental retardation: a clinical guide , 2005, Journal of Medical Genetics.

[51]  D. Skuse,et al.  X-linked genes and mental functioning. , 2005, Human molecular genetics.

[52]  Benjamin A Garcia,et al.  Analysis of protein phosphorylation by mass spectrometry. , 2005, Methods.

[53]  M. Jinek,et al.  The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.

[54]  G. Hart,et al.  Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability , 2004, Molecular and Cellular Biology.

[55]  G. Hart,et al.  Roles of the Tetratricopeptide Repeat Domain in O-GlcNAc Transferase Targeting and Protein Substrate Specificity* , 2003, Journal of Biological Chemistry.

[56]  R. Cole,et al.  Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex , 2003, Brain Research.

[57]  W. Vogel,et al.  A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? , 2001, Trends in genetics : TIG.

[58]  G. Hart,et al.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[60]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[61]  R. Sikorski,et al.  Cdc16p, Cdc23p and Cdc27p form a complex essential for mitosis. , 1994, The EMBO journal.

[62]  P. Ingham A gene that regulates the bithorax complex differentially in larval and adult cells of Drosophila , 1984, Cell.

[63]  D. Taruscio,et al.  Rare Diseases Epidemiology: Update and Overview , 2017, Advances in Experimental Medicine and Biology.

[64]  Developmental Disabilities,et al.  Intellectual disability : definition, classification, and systems of supports , 2010 .

[65]  Christine M Disteche,et al.  Dosage compensation of the active X chromosome in mammals , 2006, Nature Genetics.

[66]  H. Leonard,et al.  The epidemiology of mental retardation: challenges and opportunities in the new millennium. , 2002, Mental retardation and developmental disabilities research reviews.

[67]  M. Durkin The epidemiology of developmental disabilities in low-income countries. , 2002, Mental retardation and developmental disabilities research reviews.

[68]  C. Rieder,et al.  Greatwall kinase , 2004, The Journal of cell biology.